Influence of Lipopolysaccharide-Interacting Peptides Fusion with Endolysin LysECD7 and Fatty Acid Derivatization on the Efficacy against Acinetobacter baumannii Infection In Vitro and In Vivo
Viruses · 2024
DOI: 10.3390/v16050760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Xiaowan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fudan University, Shanghai 201203, China. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections, Anti-Bacterial Agents, Endopeptidases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acinetobacter baumannii has developed multiple drug resistances, posing a significant threat to antibiotic efficacy. LysECD7, an endolysin derived from phages, could be a promising therapeutic agent against multi-drug resistance A. baumannii. In this study, in order to further enhance the antibacterial efficiency of the engineered LysECD7, a few lipopolysaccharide-interacting peptides (Li5, MSI594 and Li5-MSI) were genetically fused with LysECD7. Based on in vitro antibacterial activity, the fusion protein Lys-Li5-MSI was selected for further modifications aimed at extending its half-life. A cysteine residue was introduced into Lys-Li5-MSI through mutation (Lys-Li5-MSIV12C), followed by conjugation with a C16 fatty acid chain via a protonation substitution reaction(V12C-C16). The pharmacokinetic profile of V12C-C16 exhibited a more favorable characteristic in comparison to Lys-Li5-MSI, thereby resulting in enhanced therapeutic efficacy against lethal A. baumannii infection in mice. The study provides valuable insights for the development of novel endolysin therapeutics and proposes an alternative therapeutic strategy for combating A. baumannii infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Fudan University, Shanghai 201203, China.
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Nanjing 210046, China.
- China State Institute of Pharmaceutical Industry, Shanghai 201203, China.
Zitieren
APA
Li, X., Shangguan, W., Yang, X., Hu, X., Li, Y., Zhao, W., Feng, M., & Feng, J. (2024). Influence of Lipopolysaccharide-Interacting Peptides Fusion with Endolysin LysECD7 and Fatty Acid Derivatization on the Efficacy against Acinetobacter baumannii Infection In Vitro and In Vivo. Viruses. https://doi.org/10.3390/v16050760
Vancouver
Li X, Shangguan W, Yang X, Hu X, Li Y, Zhao W, et al. Influence of Lipopolysaccharide-Interacting Peptides Fusion with Endolysin LysECD7 and Fatty Acid Derivatization on the Efficacy against Acinetobacter baumannii Infection In Vitro and In Vivo. Viruses. 2024. doi:10.3390/v16050760
BibTeX
@article{Li2024,
author = {Li, Xiaowan and Shangguan, Wenwen and Yang, Xiaoqian and Hu, Xiaoyue and Li, Yanan and Zhao, Wenjie and Feng, Meiqing and Feng, Jun},
title = {Influence of Lipopolysaccharide-Interacting Peptides Fusion with Endolysin LysECD7 and Fatty Acid Derivatization on the Efficacy against Acinetobacter baumannii Infection In Vitro and In Vivo},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16050760}
}
EUVIMED